Tokai names John McBride COO
This article was originally published in Scrip
Executive Summary
Tokai Pharmaceuticals, a biopharmaceutical company focused on developing new treatments for prostate cancer and other hormonally driven cancers, has named John McBride chief operating officer. Prior to joining Cambridge, Massachusetts-based Tokai Mr McBride founded and served as president of Alliance Life Science Advisors, a consulting firm focused on assisting life science companies with strategic planning, business development and financing projects.